• Brian Skorney

    Baird Equity Research
    • Tazeen Ahmad

      Bank of America Securities
      • Carter Gould

        Barclays
        • Aydin Huseynov

          Benchmark Company
          • Evan Seigerman

            BMO Capital Markets
            • Sumant Kulkarni

              Canaccord Genuity
              • Charles Duncan

                Cantor Fitzgerald
                • Neena Bitritto-Garg

                  Citi Research
                  • Phil Nadeau

                    Cowen & Company
                    • Josh Schimmer

                      Evercore ISI
                      • Chris Shibutani

                        Goldman Sachs
                        • Yatin Suneja

                          Guggenheim Securities, LLC
                          • Andrew Fein

                            H.C. Wainwright & Co.
                            • Kelly Shi

                              Jefferies LLC
                              • Anupam Rama

                                J.P. Morgan
                                • Vamil Divan

                                  Mizuho Securities USA LLC
                                  • Jeffrey Hung

                                    Morgan Stanley
                                    • Ami Fadia

                                      Needham
                                      • Jay Olson

                                        Oppenheimer
                                        • David Ansellem

                                          Piper Sandler
                                          • Brian Abrahams

                                            RBC Capital Markets, LLC
                                            • Danielle Brill

                                              Raymond James
                                              • Paul Matteis

                                                Stifel
                                                • Marc Goodman

                                                  SVP Leerink
                                                  • Laura Chico

                                                    Wedbush Securities
                                                    • Myles Minter

                                                      William Blair

                                                      Neurocrine Biosciences is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Neurocrine Biosciences's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Neurocrine Biosciences or its management. Neurocrine Biosciences does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.